Junko Tanaka

ORCID: 0000-0002-5669-4051
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Hepatocellular Carcinoma Treatment and Prognosis
  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis Viruses Studies and Epidemiology
  • Immune Cell Function and Interaction
  • COVID-19 Clinical Research Studies
  • Temporomandibular Joint Disorders
  • Viral gastroenteritis research and epidemiology
  • Glaucoma and retinal disorders
  • T-cell and B-cell Immunology
  • Liver Diseases and Immunity
  • SARS-CoV-2 detection and testing
  • Cancer Immunotherapy and Biomarkers
  • Long-Term Effects of COVID-19
  • Immunotherapy and Immune Responses
  • Diabetes and associated disorders
  • Diet, Metabolism, and Disease
  • COVID-19 epidemiological studies
  • Oral microbiology and periodontitis research
  • Vaccine Coverage and Hesitancy
  • Corneal surgery and disorders
  • Dental Research and COVID-19

Hiroshima University
2016-2025

Osaka Dental University
2012-2024

Prevention Institute
2013-2024

UNSW Sydney
2024

Japanese Society for Dialysis Therapy
2022-2023

Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital
2022

Hiroshima Prefectural Hospital
2004-2022

Hiroshima University Hospital
2022

Genesis Research Institute
2022

Center for Disease Analysis
2022

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are increasingly a cause of cirrhosis hepatocellular carcinoma globally. This burden is expected to increase as epidemics obesity, diabetes metabolic syndrome continue grow. The goal this analysis was use Markov model forecast NAFLD using currently available data.A used estimate NASH progression in eight countries based on data for adult prevalence obesity type 2 mellitus (DM). Published estimates expert...

10.1016/j.jhep.2018.05.036 article EN cc-by-nc-nd Journal of Hepatology 2018-06-07
Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain Quentin Philippot and 95 more Jérémy Manry Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Boubacar Coulibaly Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Robert L. Nussbaum Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluı́s Quintana-Murci Adam Klocperk

Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found about 10% patients with critical COVID-19 pneumonia, but not subjects asymptomatic infections. We detect auto-Abs 100-fold lower, more physiological, (100 pg/mL, 1/10 dilutions plasma) 13.6% 3,595 COVID-19, including 21% 374 > 80 years, and 6.5% 522 severe COVID-19. These antibodies also detected 18% the 1,124 deceased (aged 20 days-99 years; mean: 70...

10.1126/sciimmunol.abl4340 article EN cc-by Science Immunology 2021-08-10
Jérémy Manry Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain and 95 more Quentin Philippot Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluı́s Quintana-Murci Adam Klocperk Nelli Y. Kann Anna Shcherbina

Significance There is growing evidence that preexisting autoantibodies neutralizing type I interferons (IFNs) are strong determinants of life-threatening COVID-19 pneumonia. It important to estimate their quantitative impact on mortality upon SARS-CoV-2 infection, by age and sex, as both the prevalence these risk death increase with higher in men. Using an unvaccinated sample 1,261 deceased patients 34,159 individuals from general population, we found against IFNs strongly increased...

10.1073/pnas.2200413119 article EN cc-by Proceedings of the National Academy of Sciences 2022-05-16

Abstract This cross-sectional study aimed to investigate the post-acute consequences of COVID-19. We conducted a self-administered questionnaire survey on sequelae, psychological distress (K6), impairments in work performance (WFun), and COVID-19–related experiences stigma discrimination two designated COVID-19 hospitals Hiroshima Prefecture, Japan, between August 2020 March 2021. The prevalence sequelae was calculated by age severity. Factors independently associated with or were identified...

10.1038/s41598-022-10051-z article EN cc-by Scientific Reports 2022-04-11
Alison D. Marshall Alex Willing Abe Kairouz Evan B. Cunningham Alice Wheeler and 95 more Nicholas O’Brien Vidura Perera John W. Ward Lindsey Hiebert Louisa Degenhardt Behzad Hajarizadeh Samantha Colledge‐Frisby Matthew Hickman Danielle Jawad Jeffrey V. Lazarus Gail Matthews Andrew Scheibe Peter Vickerman Gregory J. Dore Jason Grebely Narina Sargsyants Lyudmila Suleymanova Nermin N. Salkić Marieta Simonova Tatjana Nemeth Blažić Viktor Mravčík Kristel Kivimets Riina Salupere Maia Butsashvili G. Soselia Mihály Makara Ieva Tolmane Ligita Jančorienė Sorin Stratulat Robert Flisiak Liana Gheorghe R. Cernat A. Lakhov Oksana V. Stanevich Peter Jarčuška Markus Peck‐Radosavljevic Geert Robaeys Anne Øvrehus Graham R. Foster Jussi Sutinen Martti Färkkilâ Henna Rautiainen S. Vuoti Dimitrinka Nikolova Jean‐Michel Pawlotsky Jürgen K. Rockstroh Vana Sypsa George Papatheodoridis Sigurður Ólafsson Eoin R. Feeney Elisabetta Teti Carole Seguin‐Devaux James Pocock Sarah C. Reiff NI McDougall Marc van der Valk Olav Dalgård Rui Tato Marinho John Dillon Edgar J.G. Peters Ksenija Bojović Mojca Matičič Martin Kåberg Philip Bruggmann Brendan Healy Vui Heng Chong S. Yi Joseph D. Tucker L.R. Pasaribu Junko Tanaka Elizabeth A. Ashley Mustafa Hassan Noor Syahireen Mohammed Huan‐Keat Chan Sarantuya Gidaagaya Khin Pyone Kyi Kim Hyung Joon Bum Sik Chin P.C. Baladjay Jia‐Horng Kao Tanyaporn Wansom Bernadine Cruz Barnaby Flower Esmaeelpour Ehsan M.A. Mahtab Lekey Khandu Ajeet Singh Bhadoria Maryam Alavi Praharaj Kc Saeed Hamid S. Biryukov D. Alymbaeva Arash Alaei Shokhista Bakieva Diego Flichman

10.1016/s2468-1253(23)00335-7 article EN ˜The œLancet. Gastroenterology & hepatology 2024-02-15
Paul Bastard Adrian Gervais Maki Taniguchi Liisa Saare Karita Särekannu and 95 more Tom Le Voyer Quentin Philippot Jérémie Rosain Lucy Bizien Takaki Asano Marina García-Prat Alba Parra-Martínez Mélanie Migaud Miyuki Tsumura Francesca Conti Alexandre Bélot Jacques G. Rivière Tomohiro Morio Junko Tanaka Étienne Javouhey Filomeen Haerynck Sotiriјa Duvlis Tayfun Özçelık Sevgi Keleş Yacine Tandjaoui-Lambiotte Simon Escoda M. Husain Qiang Pan‐Hammarström Lennart Hammarström Gloria Ahlijah A Haidar Camille Soudée Vincent Arseguel Hassan Abolhassani Sabina Sahanic Ivan Tancevski Yoko Nukui Seiichi Hayakawa George P. Chrousos Athanasios Michos Elizabeth‐Barbara Tatsi Filippos Filippatos Agustí Rodríguez‐Palmero Jesús Troya Imran Tipu Isabelle Meyts Lucie Roussel Sisse Rye Ostrowski Laire Schidlowski Carolina Prando Antônio Condino‐Neto Nathalie Cheikh Ahmed Aziz Bousfiha Jalila El Bakkouri Sergio Aguilera Suzan A. AlKhater Gülsüm Alkan Riccardo Castagnoli Cyril Cyrus Şefika Elmas Bozdemir Melike Emiroğlu Belgi̇n Gülhan Emine Hafize Erdeniz Nevin Hatipoğlu Gülsün Iclal Bayhan Petr Jabandžiev Saliha Kanık Yüksek Adem Karbuz Şadiye Kübra Tüter Öz Gian Luigi Marseglia Özge Metin Akcan Ahmet Osman Kılıç Aslınur Özkaya Parlakay Maria Papadaki Kateřina Slabá Esra Şevketoğlu Juan Valencia-Ramos Aysun Yahşi Antonio Aguilera J. Álvarez Antonio Antela López Gema Barbeito Castiñeiras Xabier Bello Paderne Miriam Ben García María Victoria Carral García Miriam Cebey‐López Amparo Coira M. Pájaro José Javier Costa Alcalde María José Currás Tuala Ana Isabel Dacosta Urbieta Blanca Díaz Esteban María Jesús Domínguez Santalla Cristina Fernández Juan Fernández Villaverde Cristóbal Galbán Rodríguez José Luis García Allut Luisa García Vicente Elena Giráldez Vázquez Alberto Gómez‐Carballa

We found that 19 (10.4%) of 183 unvaccinated children hospitalized for COVID-19 pneumonia had autoantibodies (auto-Abs) neutralizing type I IFNs (IFN-α2 in 10 patients: IFN-α2 only three, plus IFN-ω five, and IFN-α2, IFN-β two; nine patients). Seven (3.8%) Abs at least ng/ml one IFN, whereas the other 12 (6.6%) 100 pg/ml. The auto-Abs neutralized both unglycosylated glycosylated IFNs. also detected pg/ml 4 2,267 uninfected (0.2%) 45 (2%). odds ratios (ORs) life-threatening were, therefore,...

10.1084/jem.20231353 article EN cc-by The Journal of Experimental Medicine 2024-01-04

<i>Objective:</i> Carriers of hepatitis B virus (HBV) and C (HCV) in Japan were estimated on a national basis. <i>Methods:</i> Sera from the first-time blood donors aged 16–64 years eight jurisdictions Japanese Red Cross Blood Center during 1995–2000 tested for surface antigen (HBsAg) antibody to HCV (anti-HCV). Viremia with was be present 70% anti-HCV. <i>Results:</i> HBsAg detected 22,018 3,485,648 (0.63%) including 12,990 1,780,149 (0.73%) men 9,028...

10.1159/000076640 article EN Intervirology 2004-01-01

Background miRNAs circulating in the blood a cell-free form have been acknowledged for their potential as readily accessible disease markers. Presently, histological examination is golden standard diagnosing and grading liver disease, therefore non-invasive options are desirable. Here, we investigated if miRNA expression profile exosome rich fractionated serum could be useful determining parameters patients with chronic hepatitis C (CHC). Methodology Exosome RNA was extracted from of 64 CHC...

10.1371/journal.pone.0048366 article EN cc-by PLoS ONE 2012-10-31

<i>Objective:</i> To estimate total numbers of undiagnosed carriers hepatitis C virus (HCV) and B (HBV) in Japan. <i>Methods:</i> Area- age-specific prevalence HCV as well HBV was determined the first-time blood donors [20–39 years (n = 2,429,364)] examinees periodical health check-ups [40–74 (6,204,968 for 6,228,967 HBV)] Prevalence adolescents [5–19 (79,256 68,792 a single prefecture, that elderly (≧75 years) estimated by exponential model. infection detection...

10.1159/000324525 article EN Intervirology 2011-01-01

Objective: The aim of the study was to evaluate survival benefits liver resection (LR) compared with transarterial chemoembolization (TACE) for patients multiple hepatocellular carcinomas (HCCs). Background: Despite significant improvements in diagnostic imaging and widespread application screening programs, some HCC continue present tumors. surgical indications HCCs remain controversial. Methods: Among 77,268 reported a Japanese nationwide survey, 27,164 had HCCs. exclusion criteria were...

10.1097/sla.0000000000003192 article EN Annals of Surgery 2019-01-17

Background & AimsUltrasound-guided attenuation parameter (UGAP) is recently developed for noninvasive evaluation of steatosis. However, reports on its usefulness in clinical practice are limited. This prospective multicenter study analyzed the diagnostic accuracy grading steatosis with reference to magnetic resonance imaging–based proton density fat fraction (MRI-PDFF), a method high accuracy, large cohort.MethodsAltogether, 1010 patients chronic liver disease who underwent MRI-PDFF and UGAP...

10.1016/j.cgh.2021.11.003 article EN cc-by Clinical Gastroenterology and Hepatology 2021-11-10

The BNT162b2 and mRNA-1273 COVID-19 vaccines are the main that have been used for mass vaccination in Japan. Information on adverse reactions to Japanese population is limited.We conducted an online survey self-reported individuals who had received two doses of or vaccine. incidence events after each dose vaccine was investigated. Propensity score matching compare second vaccines.After first vaccine, 890, 853, 6401, 3965 individuals, respectively, provided complete responses. Systemic...

10.1016/j.jiac.2021.12.034 article EN cc-by Journal of Infection and Chemotherapy 2022-01-10
Homie Razavi Marı́a Buti Norah A. Terrault Stefan Zeuzem Cihan Yurdaydìn and 86 more Junko Tanaka Alessio Aghemo Ulus Salih Akarca Nasser M. Al Masri Abduljaleel Alalwan Soo Aleman Abdullah S Alghamdi Saad Alghamdi Waleed K. Al‐Hamoudi Abdulrahman Aljumah Ibrahim Altraif Tarik Asselah Ziv Ben‐Ari Thomas Berg Mia J. Biondi Sarah Blach Wornei Silva Miranda Braga Carlos Eduardo Brandão‐Mello Maurizia Rossana Brunetto Joaquín Cabezas Hugo Cheinquer Pei‐Jer Chen Myeong-Eun Cheon Wan‐Long Chuang Carla S. Coffin Nicola Coppola Antonio Craxı̀ Javier Crespo Victor de Lédinghen Ann‐Sofi Duberg Ohad Etzion Maria Lúcia Gomes Ferraz Paulo Roberto Abrão Ferreira Xavier Forns Graham R. Foster Giovanni Battista Gaeta Ivane Gamkrelidze Javier García‐Samaniego Liliana Gheorghe Pierre M. Gholam Robert G. Gish Jeffrey S. Glenn Julian Hercun Yao‐Chun Hsu Ching‐Chih Hu Jee‐Fu Huang Naveed Z. Janjua Jidong Jia Martin Kåberg Kelly Kaita Habiba Kamal Jia‐Horng Kao Loreta A. Kondili Martin Lagging Pablo Lázaro Jeffrey V. Lazarus Mei‐Hsuan Lee Young‐Suk Lim Paul J. Marotta María Cristina Navas Marcelo Contardo Moscoso Naveira Mauricio Orrego Carla Osiowy Calvin Q. Pan Mário G. Pessôa Giovanni Raimondo Alnoor Ramji Devin Razavi‐Shearer Kathryn Razavi‐Shearer Cielo Ríos Manuel Rodríguez William Rosenberg Dominique Roulot Stephen Ryder Rifaat Safadi Faisal M. Sanai Teresa Santantonio Christoph Sarrazin Daniel Shouval Frank Tacke Tammo Lambert Tergast Juan Miguel Villalobos-Salcedo Alexis Voeller Hwai‐I Yang Ming‐Lung Yu Eli Zuckerman

Hepatitis D virus (HDV) infection occurs as a coinfection with hepatitis B and increases the risk of hepatocellular carcinoma, decompensated cirrhosis, mortality compared to (HBV) monoinfection. Reliable estimates prevalence HDV disease burden are essential formulate strategies find coinfected individuals more effectively efficiently. The global HBV infections was estimated be 262,240,000 in 2021. Only 1,994,000 were newly diagnosed 2021, than half new diagnoses made China. Our initial...

10.1016/j.jhep.2023.02.041 article EN cc-by-nc-nd Journal of Hepatology 2023-04-07

Abstract More than 200 million COVID-19 survivors have lasting symptoms after recovering, but the duration and related risk factors remain uncertain. This study focused on all 6551 patients diagnosed with at a medical institution in Hiroshima from March 2020 to July 2022. In November 2022, questionnaire survey was conducted regarding post-COVID their duration. The prevalence of were illustrated using Kaplan–Meier method. Risk for over 3 months interfering daily life assessed via multivariate...

10.1038/s41598-024-54397-y article EN cc-by Scientific Reports 2024-02-16

Abstract: Recently, erythropoietin (EPO) receptors and synthesis of EPO have been identified in the brain. To clarify effects on neuronal cells, we investigated Ca 2+ uptake, intracellular concentration, membrane potential, cell survival, release biosynthesis dopamine, nitric oxide (NO) production differentiated PC12 which possess receptors. (10 ‐12 ‐10 M ) increased 45 uptake concentration cells a dose‐related manner; these increases were inhibited by nicardipine (1 μ or anti‐EPO antibody...

10.1046/j.1471-4159.1999.0722565.x article EN Journal of Neurochemistry 1999-06-01

The purpose of the present study was to evaluate effectiveness Er:YAG laser scaling and morphological histological changes laser‐scaled root surface in comparison with produced by conventional ultrasonic scaling. Fifty‐three periodontally involved human extracted teeth a band subgingival calculus were used. divided randomly into 2 groups for Laser irradiation performed at an energy output 40 mJ/pulse 10 pulses/s under water spray, probe tip contacted obliquely surface. Ultrasonic clinically...

10.1034/j.1600-0765.2000.035005266.x article EN Journal of Periodontal Research 2000-08-01

ABSTRACT Hepatitis B virus (HBV) infection is a leading cause of death in sub-Saharan Africa (SSA). Point-of-care tests for hepatitis surface antigen (HBsAg) could be an ideal tool large-scale HBV screening/treatment program SSA. Using data from the PROLIFICA (Prevention Liver Fibrosis and Cancer Africa) program, we conducted cross-sectional study to assess diagnostic accuracy three point-of-care (Determine, Vikia, Espline) detection HBsAg field or laboratory setting Gambia. In field, used...

10.1128/jcm.02980-14 article EN Journal of Clinical Microbiology 2015-01-29

Abstract Background Chronic spontaneous urticaria ( CSU ) is a common skin disorder, but its clinical course reported so far largely variable, probably due to the heterogeneity of background patients and pathogenesis this disease. Methods To reveal prognosis refractory , we retrospectively studied who suffered from for six weeks or longer at their first visit our outpatient clinic, were insufficiently controlled by standard dose antihistamine, revisited 2003 2009. Results Among 223 with 117...

10.1111/all.12078 article EN Allergy 2012-12-04
Coming Soon ...